SIRT2 Contributes to the Resistance of Melanoma Cells to the Multikinase Inhibitor Dasatinib

Malignant melanoma is the most aggressive skin cancer and can only be cured if detected early. Unfortunately, later stages of the disease do not guarantee success due to the rapid rate of melanoma cell metastasis and their high resistance to applied therapies. The search for new molecular targets an...

Full description

Saved in:
Bibliographic Details
Published in:Cancers (Basel)
Main Authors: Karwaciak, Iwona, Sałkowska, Anna, Karaś, Kaja, Sobalska-Kwapis, Marta, Walczak-Drzewiecka, Aurelia, Pułaski, Łukasz, Strapagiel, Dominik, Dastych, Jarosław, Ratajewski, Marcin
Format: Artigo
Language:Inglês
Published: MDPI 2019
Subjects:
Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC6562913/
https://ncbi.nlm.nih.gov/pubmed/31091806
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers11050673
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items